ADCT
ADCT
NYSE · Biotechnology

Adc Therapeutics Sa

$1.09
-0.02 (-1.80%)
As of Jun 21, 10:20 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +1,695.4% upside
Low Target $11.03
Average Target $19.57
High Target $23.80
Current Price $1.09
Current
$1.09
Target
$19.57
$11.03 $19.57 avg $23.80
Scenario Analysis
Bear Case
$11.03
911.9%
Low target
Base Case
$19.57
+1,695.4%
Avg target
Bull Case
$23.80
+2,083.5%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$4.98
-78.1% from high
52-Week Low
$0.78
+39.8% from low
Target vs 52W High
$19.57
+293.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.0%